Trupanion (NASDAQ:TRUP – Get Free Report) announced its earnings results on Wednesday. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05, FiscalAI reports. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm had revenue of $392.93 million for the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the previous year, the business earned $0.22 EPS. The firm’s revenue for the quarter was up 11.1% on a year-over-year basis.
Here are the key takeaways from Trupanion’s conference call:
- Subscription performance strengthened: Subscription adjusted operating income rose 24% year over year to $41.4 million, with a 15% margin, while subscription pets increased 5% to 1.125 million and retention improved to 98.37%.
- Improved acquisition economics helped drive a 9% increase in gross pet adds and 39% growth in net subscription pet additions. Management said enrolled-pet lifetime value increased 25%, supporting continued investment in customer acquisition.
- Trupanion authorized a $100 million share repurchase program after securing approval to transfer $44 million from an insurance subsidiary, adding buybacks to its capital-allocation options alongside growth investments and debt repayment.
- Management narrowed full-year 2026 guidance to $1.584 billion-$1.601 billion in revenue and $176 million-$184 million in adjusted operating income, implying approximately 19% adjusted operating income growth at the midpoint.
- Veterinary inflation remains at double-digit levels, while industry reports indicate fewer new veterinary visits; management also disclosed that its relationship with Pets Best will end after the third quarter of 2028.
Trupanion Price Performance
Shares of TRUP stock traded up $3.73 during mid-day trading on Thursday, hitting $28.12. 1,426,887 shares of the stock traded hands, compared to its average volume of 420,938. Trupanion has a twelve month low of $21.16 and a twelve month high of $57.00. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.73 and a current ratio of 1.73. The company’s 50-day simple moving average is $24.50 and its 200-day simple moving average is $26.20. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of 47.72 and a beta of 1.39.
Insider Activity
Institutional Trading of Trupanion
A number of hedge funds and other institutional investors have recently made changes to their positions in TRUP. EP Wealth Advisors LLC acquired a new stake in Trupanion during the fourth quarter valued at approximately $380,000. Susquehanna Fundamental Investments LLC grew its position in Trupanion by 216.7% in the fourth quarter. Susquehanna Fundamental Investments LLC now owns 66,368 shares of the financial services provider’s stock worth $2,480,000 after buying an additional 45,412 shares during the last quarter. Inspire Investing LLC increased its holdings in shares of Trupanion by 20.4% in the fourth quarter. Inspire Investing LLC now owns 12,624 shares of the financial services provider’s stock valued at $472,000 after buying an additional 2,137 shares in the last quarter. Engineers Gate Manager LP lifted its position in shares of Trupanion by 11.1% during the 4th quarter. Engineers Gate Manager LP now owns 130,791 shares of the financial services provider’s stock valued at $4,888,000 after acquiring an additional 13,015 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in shares of Trupanion during the 4th quarter valued at $496,000.
More Trupanion News
Here are the key news stories impacting Trupanion this week:
- Positive Sentiment: Quarterly earnings beat estimates: Trupanion reported adjusted earnings of $0.16 per share, versus the $0.11 consensus estimate. Revenue increased 11.1% year over year to $392.93 million, also ahead of expectations of $389.72 million. Trupanion Q2 Earnings and Revenues Beat Estimates
- Positive Sentiment: Improving profitability remained a focus: Management said it is growing margins, improving the economics of new enrollments and investing capital with discipline. The company generated a 1.74% net margin and 6.87% return on equity in the quarter. Trupanion Reports Second Quarter 2026 Results
- Positive Sentiment: Third-quarter outlook topped expectations: Trupanion forecast revenue of $399 million to $405 million for the third quarter, above the $397.8 million analyst consensus. Full-year revenue guidance of approximately $1.6 billion was broadly in line with expectations, reducing the risk of a guidance-related disappointment. Trupanion Q2 Key Metrics Compared With Estimates
- Positive Sentiment: Technology integration may support growth: Trupanion’s long-awaited integration with veterinary software provider Digitail is intended to reduce administrative friction and make pet enrollment easier, potentially expanding distribution and improving customer acquisition. Trupanion and Digitail Integration
- Negative Sentiment: Year-over-year EPS declined: Quarterly earnings fell from $0.22 per share in the prior-year period to $0.16, indicating that revenue growth has not yet translated into higher per-share profits despite the earnings beat. Trupanion Q2 Earnings Snapshot
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on TRUP. Bank of America lowered their price target on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a report on Monday, June 1st. Zacks Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Cantor Fitzgerald lowered their target price on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Finally, Stifel Nicolaus set a $28.00 target price on shares of Trupanion in a research note on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $41.60.
Check Out Our Latest Report on Trupanion
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Further Reading
- Five stocks we like better than Trupanion
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
